WO2007010555A3 - Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe - Google Patents

Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe Download PDF

Info

Publication number
WO2007010555A3
WO2007010555A3 PCT/IN2006/000244 IN2006000244W WO2007010555A3 WO 2007010555 A3 WO2007010555 A3 WO 2007010555A3 IN 2006000244 W IN2006000244 W IN 2006000244W WO 2007010555 A3 WO2007010555 A3 WO 2007010555A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
crystalline forms
novel crystalline
moxifloxacin hydrochloride
moxifloxacin
Prior art date
Application number
PCT/IN2006/000244
Other languages
English (en)
Other versions
WO2007010555A2 (fr
Inventor
Reddy Manne Satyanarayana
Chakilam Nagaraju
Rajan Srinivasan Thirumalai
Ramprasad Achampeta Kodanda
Original Assignee
Msn Lab Ltd
Reddy Manne Satyanarayana
Chakilam Nagaraju
Rajan Srinivasan Thirumalai
Ramprasad Achampeta Kodanda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Ltd, Reddy Manne Satyanarayana, Chakilam Nagaraju, Rajan Srinivasan Thirumalai, Ramprasad Achampeta Kodanda filed Critical Msn Lab Ltd
Publication of WO2007010555A2 publication Critical patent/WO2007010555A2/fr
Publication of WO2007010555A3 publication Critical patent/WO2007010555A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

L'invention concerne de nouvelles formes cristallines d'hydrochlorure de moxifloxacine et un procédé de préparation associé
PCT/IN2006/000244 2005-07-15 2006-07-13 Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe WO2007010555A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN948CH2005 2005-07-15
IN948/CHE/2005 2005-07-15

Publications (2)

Publication Number Publication Date
WO2007010555A2 WO2007010555A2 (fr) 2007-01-25
WO2007010555A3 true WO2007010555A3 (fr) 2007-04-12

Family

ID=37669239

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000244 WO2007010555A2 (fr) 2005-07-15 2006-07-13 Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe

Country Status (1)

Country Link
WO (1) WO2007010555A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101933076A (zh) * 2008-02-11 2010-12-29 高通Mems科技公司 调谐干涉式调制器显示器的方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
KR20150048920A (ko) * 2006-11-13 2015-05-07 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
ES2311391B1 (es) * 2007-02-07 2009-12-22 Quimica Sintetica, S.A. Forma cristalina de moxifloxacino base.
ES2316270B1 (es) * 2007-02-07 2010-02-09 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato anhidro forma iv .
EP2083010A1 (fr) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Formes polymorphes d'hydrochlorure de moxifloxacine et leurs procédés de préparation
EP2154137A1 (fr) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Formule cristalline à base de moxifloxacine
US20110212990A1 (en) * 2008-11-06 2011-09-01 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
CN101973992A (zh) * 2010-10-09 2011-02-16 河南省健康伟业医药科技有限公司 一种盐酸莫西沙星的合成方法
CN102276603B (zh) * 2011-07-14 2012-10-24 福建省福抗药业股份有限公司 一种盐酸莫西沙星的清洁制备方法
CN102952131B (zh) * 2011-08-29 2015-04-01 四川国为制药有限公司 一种盐酸莫西沙星的制备方法
CN102603738B (zh) * 2012-02-24 2013-12-11 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星化合物
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
CN112759590B (zh) * 2020-11-19 2021-12-31 内蒙古源宏精细化工有限公司 一种莫西沙星的制备方法
CN115536658A (zh) * 2022-09-09 2022-12-30 天方药业有限公司 一种盐酸莫西沙星一水合物制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091619A1 (fr) * 2003-04-09 2004-10-28 Dr. Reddy's Laboratories Limited Forme cristalline iii de chlorhydrate de moxifloxacine anhydre et procede de preparation de cette derniere
WO2005012285A1 (fr) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd Procede ameliore permettant de preparer un hydrochlorure de moxifloxacine
WO2005054240A1 (fr) * 2003-11-20 2005-06-16 Chemi Spa Polymorphes d'hydrochlorure d'acide 1-cyclopropyl-7-((s,s)-2,8-diazadicyclo(4.3.0)non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylique, et leurs methodes de preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091619A1 (fr) * 2003-04-09 2004-10-28 Dr. Reddy's Laboratories Limited Forme cristalline iii de chlorhydrate de moxifloxacine anhydre et procede de preparation de cette derniere
WO2005012285A1 (fr) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd Procede ameliore permettant de preparer un hydrochlorure de moxifloxacine
WO2005054240A1 (fr) * 2003-11-20 2005-06-16 Chemi Spa Polymorphes d'hydrochlorure d'acide 1-cyclopropyl-7-((s,s)-2,8-diazadicyclo(4.3.0)non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylique, et leurs methodes de preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101933076A (zh) * 2008-02-11 2010-12-29 高通Mems科技公司 调谐干涉式调制器显示器的方法
CN101933076B (zh) * 2008-02-11 2013-10-09 高通Mems科技公司 干涉式调制器显示器及其调谐方法

Also Published As

Publication number Publication date
WO2007010555A2 (fr) 2007-01-25

Similar Documents

Publication Publication Date Title
WO2007010555A3 (fr) Nouvelles formes cristallines d'hydrochlorure de moxifloxacine et procede de preparation associe
WO2006127933A8 (fr) Procedes d'elaboration de forme i cristalline d'hydrochlorure de cinacalcet
WO2006034451A3 (fr) Bromhydrate de clopidogrel cristallin et procede de preparation correspondant
PL1743882T3 (pl) Sposób do produkcji izocyjanianów
EP1934221A4 (fr) Procede ameliore de preparation d'un antibiotique beta-lactame
WO2005102999A3 (fr) Formes cristallines d'hydrochlorure de fexofenadine, et procedes pour les preparer
WO2008066935A3 (fr) Formes cristallines de tigécycline et procédés de préparation de celles-ci
TWI367257B (en) Process for the preparation of 2-butanol
WO2008021342A3 (fr) Formes cristallines de la 9-hydroxy-rispéridone (palipéridone)
EP1968943A4 (fr) Procede ameliore de preparation de montelukast et de ses sels pharmaceutiquement acceptables
IL188919A (en) Process for the preparation of mandipropamide and its derivatives as well as its intermediates
WO2010056656A3 (fr) Synthèse de chlorhydrate de palonosétron cristallin
EG25547A (en) Process for the preparation of amines
WO2006090268A3 (fr) Procedes de preparation d'alfuzosine et de ses sels, nouvelles formes cristallines d'alfuzosine
WO2007081907A3 (fr) Formes cristallines de la base dolasetron et leurs procédés de préparation
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
PL1737820T3 (pl) Sposób asymetrycznego uwodorniania nadający się do wytwarzania pochodnych cykloalkanoindoli
IL175695A0 (en) Process for the preparation of valacyclovir hydrochloride
IL181597A0 (en) Process for isolation of crystalline tacrolimus
WO2007098273A3 (fr) Nouvelles formes cristallines d'armodafinil et leur preparation
WO2006074230A3 (fr) Procede de fabrication d'hydrochlorure de dorzolamide
WO2007002314A3 (fr) Formes polymorphes de maleate de tegaserod
PL1928883T3 (pl) Sposób otrzymywania chlorowodorku irynotekanu
WO2009087669A3 (fr) Base libre du palonosétron et son procédé de préparation
WO2007029096A3 (fr) Nouvelles formes polymorphes de chlorhydrate de clopidogrel

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06780528

Country of ref document: EP

Kind code of ref document: A2